Confirmed Control (100%) Closed Transaction verified SupplementsConsumer Health

Nutraceutix assets acquired by Probi AB

Probi AB acquired Nutraceutix assets, a US supplements brand, on Oct 3, 2016.

Transaction summary

Target
Nutraceutix assets
Acquirer
Probi AB
Announced
2016-06-06
Completed
2016-10-03
Geography
United States
Type
Acquisition
Deal type
Control
Stake acquired
100%
First added
2026-10-31
Latest update
2026-10-31

Value and multiples

100% enterprise value

USD 105M

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

3.09x

Period: CY2015

Basis: Public source

EV / EBITDA

13.1x

EBITDA basis not stated

Basis: Public source

Basis

  • Reported value: US$105m enterprise value. Multiples use revenue of US$34m (CY2015) and EBITDA of US$8m (CY2015).

Source summary

Probi to acquire Nutraceutix, strongly expanding its North American presence and capabilities, and announces rights issue of ca SEK 600 million

Confirmed

Probi AB (publ) (“Probi”) today announces that its US subsidiary Probi USA, Inc. has signed an asset purchase agreement under which Probi will acquire the

Open source

Continue your research

Explore more comps →